Novo Ventures senior partner, Naveed Siddiqi, discussed the opportunity in a slumbering IPO market to raise larger funding rounds, in an interview with Unquote. Last year Novo Ventures participated in 19 venture financings and it expects to maintain this momentum again in 2022 across fewer but larger investments.
Read the full interview with Naveed Siddiqi here
Novo Ventures form part of the wider Novo Holdings investment group, delivering knowledge, network and capital to private and public life sciences ventures. Novo Ventures currently invests in novel science and technology across three life science sectors: biotechnology, medical technology and digital health. At the end of 2021, the Novo Ventures portfolio included 62 companies and was valued at DKK 12.8 billion.